Clinical trial
A Pilot Study of [Ga-68]PSMA PET/MRI for the Assessment of PSMA-positive Tumors
NCT02978586 is registered in ClinicalTrials.gov with Case Comprehensive Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study of [Ga-68]PSMA PET/MRI for the Assessment of PSMA-positive Tumors
- Lead sponsor
- Case Comprehensive Cancer Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 14, 2018
- Completion date
- October 25, 2019
- Enrollment
- 8 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, lung cancer, prostate cancer, prostate-specific membrane antigen positive tumors